Bal pharma

DISCLOSURES UNDER REGULATION 46 OF THE LODR

Financials

Annual Report



Quarterly Financial Results


YearDocuments
2026 Doc June_2026.pdf Doc March_2026.pdf
2025 Doc December_2025.pdf Doc June_2025.pdf Doc March_2025.pdf Doc September_2025.pdf
2024 Doc December_2024.pdf Doc June_2024.pdf Doc March_2024.pdf Doc September_2024.pdf
2023 Doc December_2023.pdf Doc June_2023.pdf Doc March_2023.pdf Doc September_2023.pdf
2022 Doc December_2022.pdf Doc June_2022.pdf Doc March_2022.pdf Doc September_2022.pdf
2021 Doc December_2021.pdf Doc June_2021.pdf Doc March_2021.pdf Doc September_2021.pdf
2020 Doc December_2020.pdf Doc June_2020.pdf Doc March_2020.pdf Doc September_2020.pdf
2019 Doc December_2019.pdf Doc June_2019.pdf Doc March_2019.pdf Doc September_2019.pdf
2018 Doc December_2018.pdf Doc June_2018.pdf Doc March_2018.pdf Doc September_2018.pdf
2017 Doc December_2017.pdf Doc June_2017.pdf Doc March_2017.pdf Doc September_2017.pdf
2016 Doc December_2016.pdf Doc June_2016.pdf Doc March_2016.pdf Doc September_2016.pdf
2015 Doc December_2015.pdf Doc June_2015.pdf Doc March_2015.pdf Doc September_2015.pdf
2014 Doc December_2014.pdf Doc June_2014.pdf Doc March_2014.pdf Doc September_2014.pdf
2013 Doc December_2013.pdf Doc June_2013.pdf Doc March_2013.pdf Doc September_2013.pdf
2012 Doc December_2012.pdf Doc June_2012.pdf Doc September_2012.pdf


Investor Relations


FileFileFileFileFile
FileFileFileFileFile
FileFileFileFileFile
FileFileFileFileFile
FileFileFileFileFile
FileFileFileFileFile
FileFileFileFileFile
FileFileFileFileFile
FileFileFileFileFile
FileFileFileFileFile
FileFileFileFileFile
FileFileFileFileFile
FileFileFileFileFile
FileFileFileFileFile
FileFileFileFileFile
FileFileFileFileFile
FileFileFileFileFile
FileFileFileFileFile
FileFileFileFileFile
FileFileFileFileFile
FileFileFileFileFile
FileFileFileFileFile
File


AGM Results/Notices


Subsidiaries


Other Relations